Investigation of Metronidazole Use during Pregnancy and Adverse Birth Outcomes
暂无分享,去创建一个
[1] R. Aubry,et al. Evaluation of Syracuse Healthy Start’s Program for Abnormal Flora Management to Reduce Preterm Birth Among Pregnant Women , 2011, Maternal and Child Health Journal.
[2] N. Sewankambo,et al. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda. , 2003, American journal of obstetrics and gynecology.
[3] David B. Callahan,et al. Bacterial Vaginosis in Pregnancy:: Diagnosis and Treatment Practices of Physicians in San Diego, California, 1999 , 2003, Sexually transmitted diseases.
[4] Alexandra Kaider,et al. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. , 2003, American journal of obstetrics and gynecology.
[5] B. Sibai,et al. Randomized Clinical Trial of Metronidazole Plus Erythromycin to Prevent Spontaneous Preterm Delivery in Fetal Fibronectin–Positive Women , 2003, Obstetrics and gynecology.
[6] D. Grové,et al. Preterm labour--is bacterial vaginosis involved? , 2002, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[7] Brett A. Collins,et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. , 2001, The New England journal of medicine.
[8] A. Ornoy,et al. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study. , 2001, Teratology.
[9] J. Carey,et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis , 2001 .
[10] Ichael,et al. METRONIDAZOLE TO PREVENT PRETERM DELIVERY IN PREGNANT WOMEN WITH ASYMPTOMATIC BACTERIAL VAGINOSIS , 2000 .
[11] H. Sørensen,et al. Safety of metronidazole during pregnancy: a cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women. , 1999, The Journal of antimicrobial chemotherapy.
[12] A. Czeizel,et al. A population based case‐control teratologic study of oral metronidazole treatment during pregnancy , 1998, British journal of obstetrics and gynaecology.
[13] R. Gibbs,et al. Assessment of office-based care of sexually transmitted diseases and vaginitis and antibiotic decision-making by obstetrician-gynecologists. , 1998, Infectious diseases in obstetrics and gynecology.
[14] A. Carvajal,et al. Is metronidazole teratogenic? A meta-analysis. , 2003, British journal of clinical pharmacology.
[15] M. Krohn,et al. Trichomonas vaginalis Associated With Low Birth Weight and Preterm Delivery , 1997, Sexually transmitted diseases.
[16] J. Hauth,et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis , 1995, The New England journal of medicine.
[17] T. Einarson,et al. Safety of metronidazole in pregnancy: a meta-analysis. , 1995, American journal of obstetrics and gynecology.
[18] L. Brubaker,et al. Pharmacokinetics of Intravaginal Metronidazole Gel , 1994, Journal of clinical pharmacology.
[19] R. Sram,et al. Genotoxicity and carcinogenicity of metronidazole. , 1994, Mutation research.
[20] W. Ray,et al. Prenatal Use of Metronidazole and Birth Defects: No Association , 1993, Obstetrics and gynecology.
[21] Henry Nider,et al. Report of the Committee on Infectious Diseases , 1989 .
[22] C. Baum,et al. Pregnancy outcomes after first-trimester vaginitis drug therapy. , 1987, Obstetrics and gynecology.
[23] F. Greenberg,et al. Possible metronidazole teratogenicity and clefting. , 1985, American journal of medical genetics.
[24] Giuseppe Attardi,et al. Midline facial defect as a teratogenic effect of metronidazole. , 1982 .
[25] J. Cantú,et al. Midline facial defect as a teratogenic effect of metronidazole. , 1982, Birth defects original article series.
[26] W. O'Fallon,et al. Lack of evidence for cancer due to use of metronidazole. , 1979, The New England journal of medicine.
[27] P. Shubik,et al. Experimental induction of hepatomas, mammary tumors, and other tumors with metronidazole in noninbred Sas:MRC(WI)BR rats. , 1979, Journal of the National Cancer Institute.